ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,334 | -34.2% | 16,282 | -8.2% | 0.00% | -100.0% |
| Q2 2023 | $460,885 | -12.1% | 17,740 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $524,255 | -4.2% | 18,254 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $547,245 | +25.8% | 18,488 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $435,000 | +5.3% | 18,269 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $413,000 | -11.8% | 18,501 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $468,000 | -34.6% | 18,637 | -6.7% | 0.00% | 0.0% |
| Q4 2021 | $716,000 | -13.7% | 19,970 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $830,000 | -3.8% | 19,493 | -2.2% | 0.00% | 0.0% |
| Q2 2021 | $863,000 | +0.8% | 19,937 | -4.9% | 0.00% | 0.0% |
| Q1 2021 | $856,000 | -9.8% | 20,974 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $949,000 | +27.9% | 20,974 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $742,000 | -5.2% | 20,974 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $783,000 | +34.3% | 20,740 | +2.9% | 0.00% | 0.0% |
| Q1 2020 | $583,000 | -45.1% | 20,150 | -1.5% | 0.00% | -50.0% |
| Q4 2019 | $1,061,000 | -7.4% | 20,457 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $1,146,000 | +32.8% | 20,870 | -1.8% | 0.00% | 0.0% |
| Q2 2019 | $863,000 | +34.2% | 21,256 | -0.0% | 0.00% | +100.0% |
| Q1 2019 | $643,000 | -12.4% | 21,263 | -2.6% | 0.00% | -50.0% |
| Q4 2018 | $734,000 | -20.3% | 21,836 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $921,000 | +30.5% | 21,836 | -1.0% | 0.00% | +100.0% |
| Q2 2018 | $706,000 | -35.2% | 22,051 | +0.7% | 0.00% | -50.0% |
| Q1 2018 | $1,089,000 | -10.9% | 21,897 | -3.4% | 0.00% | -33.3% |
| Q4 2017 | $1,222,000 | -8.8% | 22,664 | -1.9% | 0.00% | 0.0% |
| Q3 2017 | $1,340,000 | +6.4% | 23,106 | -9.4% | 0.00% | 0.0% |
| Q2 2017 | $1,259,000 | +4.4% | 25,513 | -8.1% | 0.00% | +50.0% |
| Q1 2017 | $1,206,000 | -15.2% | 27,754 | -4.5% | 0.00% | -33.3% |
| Q4 2016 | $1,422,000 | -0.5% | 29,054 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $1,429,000 | -9.9% | 29,854 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $1,586,000 | +14.3% | 29,554 | -4.7% | 0.00% | 0.0% |
| Q1 2016 | $1,387,000 | +34.0% | 31,015 | +14.4% | 0.00% | 0.0% |
| Q4 2015 | $1,035,000 | +21.8% | 27,114 | +1.5% | 0.00% | +50.0% |
| Q3 2015 | $850,000 | -3.6% | 26,714 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $882,000 | -18.6% | 26,714 | +1.6% | 0.00% | -33.3% |
| Q1 2015 | $1,083,000 | -0.5% | 26,300 | -1.5% | 0.00% | 0.0% |
| Q4 2014 | $1,088,000 | +11.6% | 26,700 | +0.4% | 0.00% | +50.0% |
| Q3 2014 | $975,000 | -20.1% | 26,586 | +1.0% | 0.00% | -33.3% |
| Q2 2014 | $1,220,000 | +36.6% | 26,335 | +21.2% | 0.00% | +50.0% |
| Q1 2014 | $893,000 | +7.7% | 21,735 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $829,000 | +60.7% | 21,735 | +0.9% | 0.00% | 0.0% |
| Q3 2013 | $516,000 | +44.9% | 21,535 | +2.9% | 0.00% | +100.0% |
| Q2 2013 | $356,000 | +20.3% | 20,935 | +2.6% | 0.00% | 0.0% |
| Q1 2013 | $296,000 | – | 20,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |